Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation

被引:104
作者
Citri, A
Gan, J
Mosesson, Y
Vereb, G
Szollosi, J
Yarden, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary
关键词
ErbB-2/HER2; Hsp90; tyrosine kinase; EGF; signal transduction;
D O I
10.1038/sj.embor.7400300
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ErbB-2/HER2 is an oncogenic tyrosine kinase that regulates a signalling network by forming ligand-induced heterodimers with several growth factor receptors of the ErbB family. Hsp90 and co-chaperones regulate degradation of ErbB-2 but not other ErbB members. Here, we report that the role of Hsp90 in modulating the ErbB network extends beyond regulation of protein stability. The capacity of ErbB-2 to recruit ligand-bound receptors into active heterodimers is limited by Hsp90, which is dissociated from ErbB-2 following ligand-induced heterodimerization. We show that Hsp90 binds a specific loop within the kinase domain of ErbB-2, thereby restraining heterodimer formation and catalytic function. These results define a role for Hsp90 as a molecular switch regulating the ErbB signalling network by limiting formation of ErbB-2-centred receptor complexes.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 15 条
  • [1] Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
    Arteaga, CL
    Ramsey, TT
    Shawver, LK
    Guyer, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) : 23247 - 23254
  • [2] Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
    Citri, A
    Alroy, I
    Lavi, S
    Rubin, C
    Xu, WP
    Grammatikakis, N
    Patterson, C
    Neckers, L
    Fry, DW
    Yarden, Y
    [J]. EMBO JOURNAL, 2002, 21 (10) : 2407 - 2417
  • [3] The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR
    Donzé, O
    Abbas-Terki, T
    Picard, D
    [J]. EMBO JOURNAL, 2001, 20 (14) : 3771 - 3780
  • [4] Mechanism of action of erbB tyrosine kinase inhibitors
    Fry, DW
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 131 - 139
  • [5] The conformational plasticity of protein kinases
    Huse, M
    Kuriyan, J
    [J]. CELL, 2002, 109 (03) : 275 - 282
  • [6] MECHANISM OF CDK ACTIVATION REVEALED BY THE STRUCTURE OF A CYCLINA-CDK2 COMPLEX
    JEFFREY, PD
    RUSO, AA
    POLYAK, K
    GIBBS, E
    HURWITZ, J
    MASSAGUE, J
    PAVLETICH, NP
    [J]. NATURE, 1995, 376 (6538) : 313 - 320
  • [7] Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions
    PinkasKramarski, R
    Soussan, L
    Waterman, H
    Levkowitz, G
    Alroy, I
    Klapper, L
    Lavi, S
    Seger, R
    Ratzkin, BJ
    Sela, M
    Yarden, Y
    [J]. EMBO JOURNAL, 1996, 15 (10) : 2452 - 2467
  • [8] Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery
    Pratt, WB
    Toft, DO
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (02) : 111 - 133
  • [9] Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37
    Prince, T
    Matts, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (38) : 39975 - 39981
  • [10] HERBIMYCIN-A INDUCES THE 20S PROTEASOME-DEPENDENT AND UBIQUITIN-DEPENDENT DEGRADATION OF RECEPTOR TYROSINE KINASES
    SEPPLORENZINO, L
    MA, ZP
    LEBWOHL, DE
    VINITSKY, A
    ROSEN, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) : 16580 - 16587